1. Older adults in hematologic malignancy trials: Representation, barriers to participation and strategies for addressing underrepresentation. (September 2020) Authors: Kanapuru, Bindu; Singh, Harpreet; Kwitkowski, Virginia; Blumenthal, Gideon; Farrell, Ann T.; Pazdur, Richard Journal: Blood reviews Issue: Volume 43(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature. Issue 9 (29th April 2020) Authors: Nguyen, Michelle Nadeau; Nayernama, Afrouz; Jones, S. Christopher; Kanapuru, Bindu; Gormley, Nicole; Waldron, Peter E. Journal: American journal of hematology Issue: Volume 95:Issue 9(2020:Sep.) Page Start: E218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Roadmap to 2030 for Drug Evaluation in Older Adults. Issue 2 (8th November 2021) Authors: Liu, Qi; Schwartz, Janice B.; Slattum, Patricia W.; Lau, S.W. Johnny; Guinn, Daphne; Madabushi, Rajanikanth; Burckart, Gilbert; Califf, Robert; Cerreta, Francesca; Cho, Carolyn; Cook, Jack; Gamerman, Jamie; Goldsmith, Paul; van der Graaf, Piet H.; Gurwitz, Jerry H.; Haertter, Sebastian; Hilmer, S... Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 2(2022) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗